SWP
AVXL icon

Strategic Wealth Partners’s Anavex Life Sciences AVXL Stock Holding History

Strategic Wealth Partners’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,500
Closed -$4K – 638
2018
Q2 		$4K Buy
+1,500
New +$4.19K ﹤0.01% 655

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Strategic Wealth Partners's AVXL Position: Q3 2018 in Review

Strategic Wealth Partners sold out of Anavex Life Sciences (AVXL) in Q3 2018, closing a stake of 1,500 shares — an estimated $4K sold.

Strategic Wealth Partners first reported a position in AVXL in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 48 funds tracked by Wall St. Rank hold AVXL as of Q3 2018.

  • Strategic Wealth Partners reported no remaining Anavex Life Sciences position as of Q3 2018 after selling out during the quarter.
  • Strategic Wealth Partners sold 1,500 Anavex Life Sciences shares in Q3 2018, an estimated $4K.
  • Strategic Wealth Partners first reported a position in Anavex Life Sciences in Q2 2018 and held it in 1 quarter.
  • Strategic Wealth Partners's Anavex Life Sciences position peaked at $4K in Q2 2018.
  • 48 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2018.

Based on Strategic Wealth Partners's 13F filing for Q3 2018, filed 6 Dec 2018.